eGFR Decline in Patients with IgA Nephropathy Treated with Nefecon or Placebo: Results from the 2-Year NefIgArd Phase 3 Trial


Lafayette R. A., Kristensen J., Stone A. M., Floege J., Tesar V., Trimarchi H., ...More

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY : JASN, vol.34, no.11S, pp.8, 2023 (Scopus)